FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313339927> ?p ?o ?g. }

• W4313339927 endingPage "101582" @default.
• W4313339927 startingPage "101582" @default.
• W4313339927 abstract "The effect of Sodium-glucose cotransporter-2 (SGLT2) inhibitors on the occurrence of AF and stroke remains unclear due to underpowered individual studies. We aim to conduct a meta-analysis including all studies that have evaluated the effects of SGLT2 inhibitors on the occurrence of AF and stroke. We queried electronic databases (PubMed, Cochrane CENTRAL and ClinicalTrials.gov) for randomized controlled trials assessing the effect of SGLT2 inhibitors. Trials were selected if they reported 1 or both of the pre-specified outcomes of stroke and AF. Results were pooled using a random-effects model. Subgroup analysis was conducted to study patients with T2DM, HF, CVD and CKD. 56 trials comprising 111,773 patients were included. SGLT2 inhibitors significantly reduced the incidence of AF across all studies (RR:0.87; 95%CI, [0.76-0.99], P=0.03, I^2=0%) especially when used as monotherapy (RR:0.87; 95%CI, [0.77-0.99], P=0.04, I^2=0%) and among T2DM patients (RR:0.83; 95%CI, [0.72-0.97], P=0.02, I^2=0%). The risk of stroke was not reduced after treatment with SGLT2 inhibitors (RR:0.97; 95%CI, [0.89-1.07], P=0.56, I^2=0%) and this was consistent when given as monotherapy (RR:0.98; 95%CI, [0.89-1.07], P=0.62, I^2=0%) or combination therapy (RR:0.58; 95%CI, [0.17-1.95], P=0.38, I^2=0%). This result was consistent among the 3 subpopulations: T2DM, CVD and HF, however benefit was seen in patients with CKD (eGFR<90) (RR:0.85; 95%CI, [0.75-0.97], P=0.02, I^2=0%). SGLT2 inhibitors significantly reduce the incidence of atrial fibrillation, and this effect is primarily seen when given as monotherapy and in patients with T2DM. However, they have no significant effect on the incidence of stroke, except for in patients with Stage 2 CKD and beyond (eGFR<90)." @default.
• W4313339927 created "2023-01-06" @default.
• W4313339927 creator A5002533394 @default.
• W4313339927 creator A5003528406 @default.
• W4313339927 creator A5008301626 @default.
• W4313339927 creator A5014909272 @default.
• W4313339927 creator A5015619402 @default.
• W4313339927 creator A5037407214 @default.
• W4313339927 creator A5037722853 @default.
• W4313339927 creator A5067478305 @default.
• W4313339927 creator A5073803611 @default.
• W4313339927 creator A5076755341 @default.
• W4313339927 creator A5088657566 @default.
• W4313339927 date "2023-04-01" @default.
• W4313339927 modified "2023-10-01" @default.
• W4313339927 title "The Effect of Sodium-Glucose Co-Transporter 2 Inhibitors on Stroke and Atrial Fibrillation: A Systematic Review and Meta-Analysis" @default.
• W4313339927 cites W2098923148 @default.
• W4313339927 cites W2109887283 @default.
• W4313339927 cites W2125435699 @default.
• W4313339927 cites W2134833483 @default.
• W4313339927 cites W2146264128 @default.
• W4313339927 cites W2614057140 @default.
• W4313339927 cites W2626446274 @default.
• W4313339927 cites W2790694951 @default.
• W4313339927 cites W2793012836 @default.
• W4313339927 cites W2833091206 @default.
• W4313339927 cites W2899764361 @default.
• W4313339927 cites W2900413769 @default.
• W4313339927 cites W3080459529 @default.
• W4313339927 cites W3089283105 @default.
• W4313339927 cites W3091750031 @default.
• W4313339927 cites W3101044784 @default.
• W4313339927 cites W3118913541 @default.
• W4313339927 cites W3137149723 @default.
• W4313339927 cites W3154580191 @default.
• W4313339927 cites W3157077274 @default.
• W4313339927 doi "https://doi.org/10.1016/j.cpcardiol.2022.101582" @default.
• W4313339927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36584726" @default.
• W4313339927 hasPublicationYear "2023" @default.
• W4313339927 type Work @default.
• W4313339927 citedByCount "1" @default.
• W4313339927 countsByYear W43133399272023 @default.
• W4313339927 crossrefType "journal-article" @default.
• W4313339927 hasAuthorship W4313339927A5002533394 @default.
• W4313339927 hasAuthorship W4313339927A5003528406 @default.
• W4313339927 hasAuthorship W4313339927A5008301626 @default.
• W4313339927 hasAuthorship W4313339927A5014909272 @default.
• W4313339927 hasAuthorship W4313339927A5015619402 @default.
• W4313339927 hasAuthorship W4313339927A5037407214 @default.
• W4313339927 hasAuthorship W4313339927A5037722853 @default.
• W4313339927 hasAuthorship W4313339927A5067478305 @default.
• W4313339927 hasAuthorship W4313339927A5073803611 @default.
• W4313339927 hasAuthorship W4313339927A5076755341 @default.
• W4313339927 hasAuthorship W4313339927A5088657566 @default.
• W4313339927 hasConcept C120665830 @default.
• W4313339927 hasConcept C121332964 @default.
• W4313339927 hasConcept C126322002 @default.
• W4313339927 hasConcept C127413603 @default.
• W4313339927 hasConcept C168563851 @default.
• W4313339927 hasConcept C187960798 @default.
• W4313339927 hasConcept C2779161974 @default.
• W4313339927 hasConcept C2780645631 @default.
• W4313339927 hasConcept C44249647 @default.
• W4313339927 hasConcept C61511704 @default.
• W4313339927 hasConcept C71924100 @default.
• W4313339927 hasConcept C78519656 @default.
• W4313339927 hasConcept C82789193 @default.
• W4313339927 hasConcept C90924648 @default.
• W4313339927 hasConcept C95190672 @default.
• W4313339927 hasConceptScore W4313339927C120665830 @default.
• W4313339927 hasConceptScore W4313339927C121332964 @default.
• W4313339927 hasConceptScore W4313339927C126322002 @default.
• W4313339927 hasConceptScore W4313339927C127413603 @default.
• W4313339927 hasConceptScore W4313339927C168563851 @default.
• W4313339927 hasConceptScore W4313339927C187960798 @default.
• W4313339927 hasConceptScore W4313339927C2779161974 @default.
• W4313339927 hasConceptScore W4313339927C2780645631 @default.
• W4313339927 hasConceptScore W4313339927C44249647 @default.
• W4313339927 hasConceptScore W4313339927C61511704 @default.
• W4313339927 hasConceptScore W4313339927C71924100 @default.
• W4313339927 hasConceptScore W4313339927C78519656 @default.
• W4313339927 hasConceptScore W4313339927C82789193 @default.
• W4313339927 hasConceptScore W4313339927C90924648 @default.
• W4313339927 hasConceptScore W4313339927C95190672 @default.
• W4313339927 hasIssue "4" @default.
• W4313339927 hasLocation W43133399271 @default.
• W4313339927 hasLocation W43133399272 @default.
• W4313339927 hasOpenAccess W4313339927 @default.
• W4313339927 hasPrimaryLocation W43133399271 @default.
• W4313339927 hasRelatedWork W2054144706 @default.
• W4313339927 hasRelatedWork W2114346778 @default.
• W4313339927 hasRelatedWork W2335438131 @default.
• W4313339927 hasRelatedWork W2794099597 @default.
• W4313339927 hasRelatedWork W3045777797 @default.
• W4313339927 hasRelatedWork W3095869936 @default.
• W4313339927 hasRelatedWork W3149153096 @default.
• W4313339927 hasRelatedWork W3212844877 @default.
• W4313339927 hasRelatedWork W4212933565 @default.

• next